Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study

被引:29
|
作者
Shea, Christopher M. [1 ]
Gertner, Alex K. [1 ]
Green, Sherri L. [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27599 USA
关键词
Primary health care; medication assisted treatment; opioid use disorder; ECHO; implementation barriers; PROJECT ECHO; SPECIALISTS; ADDICTION; CAPACITY; CARE;
D O I
10.1080/08897077.2019.1694617
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Medication treatment for opioid use disorder (M-OUD) is underutilized, despite research demonstrating its effectiveness in treating opioid use disorder (OUD). The UNC Extension for Community Healthcare Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) project was designed to evaluate interventions for reducing barriers to delivery of M-OUD by rural primary care providers in North Carolina. A key element was tele-conferenced sessions based on the University of New Mexico Project ECHO model, comprised of case discussions and didactic presentations using a "hub and spoke" model, with expert team members at the hub site and community-based providers participating from their offices (i.e., spoke sites). Although federal funders have promoted use of the model, barriers for providers to participate in ECHO sessions are not well documented. Methods: UNC ECHO for MAT included ECHO sessions, provider-to-provider consultations, and practice coaching. We conducted 20 semi-structured interviews to assess perceived usefulness of the UNC ECHO for MAT intervention, barriers to participation in the intervention, and persistent barriers to prescribing M-OUD. Results: Participants were generally satisfied with ECHO sessions and provider-to-provider consultations; however, perceived value of practice support was less clear. Primary barriers to participating in ECHO sessions were timing and length of sessions. Participants recommended recording ECHO sessions for viewing later, and some thought incentives for either the practice or provider could facilitate participation. Providers who had participated in ECHO sessions valued the expertise on the expert team; the team's ability to develop a supportive, collegial environment; and the value of a community of providers interested in learning from each other, particularly through case discussions. Conclusions: Despite the perceived value of ECHO, barriers may prevent consistent participation. Also, barriers to M-OUD delivery remain, including some that ECHO alone cannot address, such as Medicaid and private-insurer policies and availability of psychosocial resources.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [1] Implementation of office-based buprenorphine treatment for opioid use disorder
    Carroll, Emily
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2022, 34 (01) : 196 - 204
  • [2] Integrating buprenorphine treatment of opioid dependence into office-based practice: A qualitative study of facilitators and barriers
    Barry, D. T.
    Jones, E. S.
    Tetrault, J. M.
    Becker, W. C.
    Irwin, K.
    Sullivan, L. E.
    O'Connor, P.
    Schottenfeld, R. S.
    Fiellin, D. A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 331 - 332
  • [3] Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder
    Qian, Gary
    Rao, Isabelle
    Humphreys, Keith
    Owens, Douglas K.
    Brandeau, Margaret L.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 243
  • [4] Handbook of Office-Based Buprenorphine Treatment of Opioid Treatment
    Liberto, Joseph G.
    PSYCHIATRIC SERVICES, 2012, 63 (05) : 515 - 515
  • [5] Providing Office-Based Treatment of Opioid Use Disorder
    Wilson, Courtenay Gilmore
    Fagan, E. Blake
    ANNALS OF FAMILY MEDICINE, 2017, 15 (05) : 481 - 481
  • [6] Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
    Barry, Declan T.
    Irwin, Kevin S.
    Jones, Emlyn S.
    Becker, William C.
    Tetrault, Jeanette M.
    Sullivan, Lynn E.
    Hansen, Helena
    O'Connor, Patrick G.
    Schottenfeld, Richard S.
    Fiellin, David A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (02) : 218 - 225
  • [7] Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
    Declan T. Barry
    Kevin S. Irwin
    Emlyn S. Jones
    William C. Becker
    Jeanette M. Tetrault
    Lynn E. Sullivan
    Helena Hansen
    Patrick G. O’Connor
    Richard S. Schottenfeld
    David A. Fiellin
    Journal of General Internal Medicine, 2009, 24 : 218 - 225
  • [8] Buprenorphine for Office-Based Treatment of Patients With Opioid Addiction
    Manlandro, James J., Jr.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2005, 105 (06): : S8 - S13
  • [9] Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence
    Weinstein, David D.
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (02) : 256 - 256
  • [10] Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence
    Balon, Richard
    ANNALS OF CLINICAL PSYCHIATRY, 2013, 25 (01) : 74 - 76